Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90
Allogeneic natural killer (aNK) cell adoptive therapy has the potential to dramatically impact clinical outcomes of glioblastoma multiforme (GBM). However, in order to exert therapeutic activity, NK cells require tumor expression of ligands for activating receptors, such as MHC Class I peptide A/B (...
Enregistré dans:
Auteurs principaux: | Tanmoy Saha, Amanda A. van Vliet, Chunxiao Cui, Jorge Jimenez Macias, Arpita Kulkarni, Luu Nhat Pham, Sean Lawler, Jan Spanholtz, Anna-Maria Georgoudaki, Adil Doganay Duru, Aaron Goldman |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e47ed6b00c7f48eaa54b2fa0f80f11a6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Anti-Tumor Activity of Expanded PBMC-Derived NK Cells by Feeder-Free Protocol in Ovarian Cancer
par: Minhua Chen, et autres
Publié: (2021) -
Neoplasia blástica de células dendríticas plasmocitoides. Casos clínicos
par: Avilés-Salas,Alejandro, et autres
Publié: (2017) -
Leucemia de células natural killer: Caso clínico
par: Guerrero A,Mario, et autres
Publié: (2005) -
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
par: Erica L. Heipertz, et autres
Publié: (2021) -
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
par: Yan-Ruide Li, et autres
Publié: (2021)